Comparative study of avian influenza virus propagation in the cell culture and chick embryos


Cite item

Full Text

Abstract

Comparative reproduction studies of 7 avian influenza virus strains (H5N1, H5N2, H3N2, H4N6, H7N7) in Vero and MDCK cell lines have indicated that the MDCK cell line is an optimal substrate for all study strains. The maximum viral output depends on trypsin concentrations and infection doses, which can differ for individual viral strains. The use of the optimal parameters of avian influenza virus replication in the MDCK cell lines yields virus titers comparable with virus reproduction in the chick embryos. The reproductive studies of the same avian influenza virus strains in chick embryos have shown that the maximum virus multiplication is seen when observing the optimum incubation time for infected embryos, which may be dissimilar in different strains. A considerable increase in hemagglutinin output can be achieved on adding trypsin to the infected chick embryos.

References

  1. Гендон Ю. З. Культуральные гриппозные вакцины // Вопр. вирусол. - 2002. - № 6. - С. 4-11.
  2. Гендон Ю. З., Маркушин С. Г., Акопова И. И. и др. Разработка культуральной живой холодадаптированной реассортантной гриппозной вакцины // Вопр. вирусол. - 2003. - № 2. - C. 12-17.
  3. Гендон Ю. З. Эпизоотии гриппа птиц и борьба с ними // Журн. микробиол. - 2006. - № 5. - С. 17-28.
  4. Audsley J., Tannock G. The role of cell culture vaccines in the control of the next influenza pandemic // Expert Opin. Biol. Ther. - 2004. - Vol. 4. - P. 709-717.
  5. Brands R., Visser J., Medema J. et al. Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine // Dev. Biol. Stand. - 1999. - Vol. 98. - P. 93-100.
  6. Kendal A., Pereira M., Skehel J. Concepts and Procedures for Laboratory-Based Influenza Surveillance, Distributed by the Viral Diseases Unit // WHO, Geneva, 1984.
  7. Kistner O., Barrett P., Mundt W. et al. A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale production // Wien. Klin. Wschr. - 1999. - Vol. 111. - P. 207-214.
  8. Requirements for the Use of animal Cells as in Vitro Substrates for the Production of Biologicals, WHO Expert Committee on Biological Standardization // WHO Techn. Rep. Ser. - 1998. - N 878 (annex 1).
  9. Schild G., Oxford J., de Jong J. et al. Evidence for host-cell selection of influenza virus antigenic variants // Nature. - 1983. - Vol. 303. - P. 706-709.
  10. Stephenson L., Democratis J. Influenza: current threat from avian influenza // Br. Med. Bull. - 2006. - Vol. 75-76. - P. 63-80.
  11. WHO. Cell culture as a substrate for the production of influenza vaccines; memorandum from a WHO meeting // Bull. Wed Hlth Org. - 1995. - Vol. 73. - P. 431-435.
  12. WHO. WHO Manual on Animal Influenza Diagnosis and Surveillance. WHO, Geneva, 2002.
  13. Wood J., Robertson J. Development of a vaccine for humans against highly pathogenic avian influenza virus // Euro Surveillance. - 2004. - Vol. 8. - P. 31-32.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2009 Vasil'ev Y.M., Rudneva I.A., Koptyaeva I.B., Vasilyev Y.M., Rudneva I.A., Koptyaeva I.B.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-77676 от 29.01.2020.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies